[EYES] Second Sight Medical Products, Inc.

Overview

Type of security: Stock

Sector:

Industry:

Market Capitalization: 145.96 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.13 Change: 0.08 (3.9%)
Ext. hours: Change: 0 (0%)

chart EYES

Refresh chart

Strongest Trends Summary For EYES

EYES is in the long-term down -59% below S&P in 3 years and down -97% below S&P in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Second Sight Medical Products, Inc., a medical device company, develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients. The company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. It has operations in North America, Europe, and the Middle East. The company was formerly known as Second Sight LLC. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.

Fundamental Ratios
Shares Outstanding36.04 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 178.23% Sales Growth - Q/Q11.84% P/E
P/E To EPS Growth P/S32.87 P/BV4.79 Price/Cash Per Share4.91
Price/Free Cash Flow-8.27 ROA-85.46% ROE-110.7% ROI
Current Ratio4.27 Quick Ratio3.56 Long Term Debt/Equity Debt Ratio0.3
Gross Margin7.05% Operating Margin-489.6% Net Profit Margin-759.41% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities290 K Cash From Investing Activities4.83 M Cash From Operating Activities-5.03 M Gross Profit400 K
Net Profit-4.96 M Operating Profit-4.96 M Total Assets39.46 M Total Current Assets38.4 M
Total Current Liabilities9 M Total Debt Total Liabilities9 M Total Revenue1.7 M
Technical Data
High 52 week1.97 Low 52 week0.65 Last close0.84 Last change5.66%
RSI39.05 Average true range0.05 Beta0.68 Volume438.22 K
Simple moving average 20 days0.2% Simple moving average 50 days7.19% Simple moving average 200 days-8.75%
Performance Data
Performance Week4.87% Performance Month8.67% Performance Quart-12.04% Performance Half20.69%
Performance Year-44.74% Performance Year-to-date-5.19% Volatility daily3.12% Volatility weekly6.97%
Volatility monthly14.28% Volatility yearly49.46% Relative Volume704.36% Average Volume218.28 K
New High New Low

News

2020-05-13 12:30:04 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q1 Release

2020-05-05 13:08:00 | Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock

2020-04-30 20:43:00 | Second Sight Medical Products Announces Pricing of Public Offering of Common Stock

2020-04-28 08:00:00 | Second Sight Medical Products Provides Business Update

2020-04-01 09:04:01 | Company News for Apr 1, 2020

2020-03-30 13:15:00 | Second Sight Announces Employee Layoffs, Intent to Wind Down Operations and Appointment of Matthew Pfeffer as Acting CEO

2020-03-26 23:10:16 | Edited Transcript of EYES earnings conference call or presentation 19-Mar-20 8:30pm GMT

2020-03-19 17:15:09 | Second Sight Medical Products EYES Reports Q4 Loss, Misses Revenue Estimates

2020-03-19 16:05:00 | Second Sight Reports Fourth Quarter and Full Year 2019 Financial Results

2020-03-19 14:30:00 | Second Sight Medical Products, Inc. to Host Earnings Call

2020-03-16 08:00:00 | Second Sight to Discuss Fourth Quarter and Year-End 2019 Financial Results on March 19, 2020 Conference Call

2020-03-12 16:15:00 | Second Sight Announces Departure of Will McGuire, President and CEO, and Appointment of Gregg Williams as Acting CEO

2020-03-04 12:30:05 | Will Second Sight Medical Products EYES Report Negative Q4 Earnings? What You Should Know

2020-02-28 08:07:17 | Is Second Sight Medical Products, Inc. NASDAQ:EYES Excessively Paying Its CEO?

2020-01-14 07:43:30 | Can Second Sight Medical Products NASDAQ:EYES Afford To Invest In Growth?

2019-11-21 14:31:23 | Edited Transcript of EYES earnings conference call or presentation 14-Nov-19 9:30pm GMT

2019-11-14 17:35:10 | Second Sight Medical Products EYES Reports Q3 Loss, Lags Revenue Estimates

2019-11-14 16:05:00 | Second Sight Reports Third Quarter 2019 Financial Results

2019-11-07 10:30:03 | Will Second Sight Medical Products EYES Report Negative Earnings Next Week? What You Should Know

2019-11-07 06:51:54 | What Kind Of Investor Owns Most Of Second Sight Medical Products, Inc. NASDAQ:EYES?

2019-11-05 16:30:00 | Second Sight to Discuss Third Quarter 2019 Financial Results on November 14, 2019 Conference Call

2019-10-30 10:33:02 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q3 Release

2019-10-02 08:30:13 | Imagine Owning Second Sight Medical Products NASDAQ:EYES And Trying To Stomach The 77% Share Price Drop

2019-10-01 08:00:00 | Second Sight Announces $2.4 Million, Four-Year Grant from National Institutes of Health to Develop Spatial Localization and Mapping Technology

2019-09-02 09:54:31 | Edited Transcript of EYES earnings conference call or presentation 6-Aug-19 8:30pm GMT

2019-08-28 08:00:00 | Second Sight to Present at September Investor Conferences

2019-08-27 10:33:28 | How Many Second Sight Medical Products, Inc. NASDAQ:EYES Shares Did Insiders Buy, In The Last Year?

2019-08-06 19:05:11 | Second Sight Medical Products EYES Reports Q2 Loss, Tops Revenue Estimates

2019-08-06 16:05:00 |  Second Sight Reports Second Quarter 2019 Financial Results

2019-07-30 16:30:00 | Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call

2019-07-30 10:38:02 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q2 Release

2019-07-11 10:53:02 | How Much is Second Sight Medical Products, Inc.'s NASDAQ:EYES CEO Getting Paid?

2019-06-25 16:05:00 | Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility Study

2019-05-16 17:00:00 | Second Sight to Present at 20th Annual B. Riley FBR Investor Conference

2019-05-15 22:39:23 | Edited Transcript of EYES earnings conference call or presentation 15-May-19 8:30pm GMT

2019-05-15 17:25:09 | Second Sight Medical Products EYES Reports Q1 Loss, Misses Revenue Estimates

2019-05-15 16:15:40 | Second Sight Medical Products: 1Q Earnings Snapshot

2019-05-15 16:05:00 | Second Sight Reports First Quarter 2019 Financial Results

2019-05-15 16:01:00 | Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System

2019-05-08 08:00:00 | Second Sight to Discuss First Quarter 2019 Financial Results on May 15, 2019 Conference Call

2019-05-02 10:32:02 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q1 Release

2019-04-17 09:13:22 | Imagine Owning Second Sight Medical Products NASDAQ:EYES And Trying To Stomach The 80% Share Price Drop

2019-04-11 08:00:00 | Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting

2019-04-04 10:49:02 | Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv

2019-04-03 07:57:11 | Get Over Bargain Hunting: Tap 5 Stocks With Rising P/E

2019-03-19 12:26:04 | Zacks.com featured highlights include: Catabasis, Ligand, Key, Carbonite and Second Sight

2019-03-18 09:02:01 | Rising P/E an Overlooked Criterion: 5 Top Stocks

2019-03-13 23:40:11 | Edited Transcript of EYES earnings conference call or presentation 13-Mar-19 8:30pm GMT

2019-03-13 16:34:13 | Second Sight Medical Products: 4Q Earnings Snapshot

2019-03-13 16:05:00 | Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results